Page last updated: 2024-09-02

morpholinoanthracycline mx2 and staurosporine

morpholinoanthracycline mx2 has been researched along with staurosporine in 1 studies

Compound Research Comparison

Studies
(morpholinoanthracycline mx2)
Trials
(morpholinoanthracycline mx2)
Recent Studies (post-2010)
(morpholinoanthracycline mx2)
Studies
(staurosporine)
Trials
(staurosporine)
Recent Studies (post-2010) (staurosporine)
531506,27258976

Protein Interaction Comparison

ProteinTaxonomymorpholinoanthracycline mx2 (IC50)staurosporine (IC50)
Chain A, Ribosomal protein S6 kinase alpha-1Homo sapiens (human)0.0003
Chain X, Tyrosine-protein kinase LynHomo sapiens (human)0.0013

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adachi, M; Date, M; Fukuhara, S; Katsurada, T; Kido, H; Kimura, T; Kishimoto, Y; Yamanaka, Y1

Other Studies

1 other study(ies) available for morpholinoanthracycline mx2 and staurosporine

ArticleYear
Induction of apoptosis in megakaryocytic leukemia cell lines by MX2, a morpholino anthracycline.
    Experimental hematology, 1997, Volume: 25, Issue:10

    Topics: Antibiotics, Antineoplastic; Apoptosis; Benzoquinones; Carubicin; DNA Fragmentation; Enzyme Inhibitors; Humans; Ionomycin; Lactams, Macrocyclic; Leukemia, Megakaryoblastic, Acute; Megakaryocytes; Microscopy, Electron; Protein-Tyrosine Kinases; Quinones; Rifabutin; Staurosporine; Tumor Cells, Cultured

1997